Navigation Links
Amicus Therapeutics Announces Third Quarter 2010 Financial Results
Date:11/8/2010

CRANBURY, N.J., Nov. 8, 2010 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD) today announced financial results for the quarter ended September 30, 2010, provided an update on its product development pipeline, including its Phase 3 program with Amigal (migalastat HCl) for the treatment of Fabry disease and reaffirmed the financial strength of the Company.  

John F. Crowley, Chairman and CEO of Amicus Therapeutics stated, "During the third quarter we made significant progress further establishing Amicus as a leader in the research and development of new treatments for rare diseases.  Our strategic partnership with GSK not only supports the potential for success with the Amigal program but also provides us with multiple strategic options for continued growth.  Moving forward, we intend to judiciously invest in our pipeline and to explore a series of additional partnerships, all while ensuring that our financial strength allows us to fund our operations and capital expenditures through the anticipated U.S. commercial launch of Amigal."

Third Quarter Financial SummaryAs of September 30, 2010, Amicus held $57.6 million of cash, cash equivalents, and marketable securities.

For the three months ended September 30, 2010, Amicus reported a net loss of $15.4 million, or $0.56 per share attributable to common stockholders, compared to a net loss of $13.4 million, or $0.59 per share attributable to common stockholders for the same period in 2009.

Pipeline OverviewAmigal (migalastat HCl) for the Treatment of Fabry DiseaseOn October 29, 2010, Amicus announced a definitive agreement with GlaxoSmithKline PLC (GSK) to develop and commercialize Amigal™ (migalastat HCl), currently in Phase 3 for the treatment of Fabry disease.  Under the terms of the agreement, GSK received an exclusive worldwide license to d
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease
2. Amicus Therapeutics to Host Conference Call and Webcast to Discuss Exclusive Worldwide Agreement with GSK to Develop and Commercialize Amigal™ for Fabry Disease
3. Amicus Therapeutics to Host Its Second Quarter 2010 Financial Results Conference Call and Webcast on August 5, 2010
4. Amicus CEO Represents BIO on Rare Diseases at U.S. Senate Committee on Health, Education, Labor and Pensions Bipartisan Hearing
5. Alzheimers Drug Discovery Foundation Funds Amicus Therapeutics To Advance Pharmacological Chaperone Technology
6. Fenwal Receives FDA Clearance for Amicus(R) Separator With Wireless Connectivity
7. Amicus Therapeutics to Host its First Quarter 2010 Financial Results Conference Call and Webcast on May 6, 2010
8. FDA Clears the Fenwal Amicus(R) Separator System for Collecting Platelets in New Additive Solution
9. Amicus Therapeutics Announces Closing of $18.5 Million Registered Direct Offering of Common Stock
10. Amicus Therapeutics Announces $18.5 Million Registered Direct Offering of Common Stock
11. Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 2014   TRU-D SmartUVC LLC, producers of ... announced today that the General Services Administration has awarded ...   This newly formed agreement will allow ... government purchasers, including Department of Veteran Affairs and Department ... contacts purchasing solutions for the Ebola effort in ...
(Date:12/22/2014)... , Dec. 22, 2014 Cyberonics, Inc. (NASDAQ: ... the treatment and management of epilepsy, today announced it will ... Conference on Wednesday, January 14, 2015, in San ... President and Chief Executive Officer, will speak at 11:00 AM ... be accessed by clicking on the Investor Relations link on ...
(Date:12/22/2014)... Maine , Dec. 22, 2014  Mark ... analysis brief providing a summary of the 2015 ... plan enrollment trends.  According to ... for Planning and Evaluation, Department of Health and ... were enrolled in individual medical plans through the ...
Breaking Medicine Technology:TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2Insights into the Marketplace and Individual Market Growth 2
... Watson Pharmaceuticals, Inc. (NYSE: WPI ) today ... Abbreviated New Drug Application (ANDA) with the U.S. Food ... Citrate Tablets, 25, 50 and 100 mg. Watson,s Sildenafil ... Viagra®, which is indicated for the treatment of erectile ...
... 2, 2011 DURECT Corporation (Nasdaq: DRRX ... Officer and Executive Vice President, Corporate Strategy has resigned ... Stauffer and DURECT have entered into a consulting agreement ... http://photos.prnewswire.com/prnh/20020717/DRRXLOGO ) "We appreciate all of Joe,s ...
Cached Medicine Technology:Watson Confirms Viagra® Patent Challenge 2DURECT Announces Resignation of Chief Medical Officer 2
(Date:12/26/2014)... CA (PRWEB) December 26, 2014 ... score of 3.1 out of 5. This score reflects ... low level of product specialization, low switching costs and ... is reduced by the low availability of substitutes for ... world price of steel and aluminum, key inputs in ...
(Date:12/26/2014)... (PRWEB) December 26, 2014 India Network ... insurance in the USA, announced today a new version ... members in choosing the right plan for their visiting ... complexity out of the selection process when choosing an ... age group with only a few clicks. Many elderly ...
(Date:12/25/2014)... December 26, 2014 This is a ... the global Sterilizers industry with a focus on the ... market status of the Sterilizers manufacturers and is a ... individuals interested in the industry. This report provides a ... and manufacturing technology. In this part, the report presents ...
(Date:12/25/2014)... “Every three months the trends for evening ... dress will be one of the hottest styles in the ... Today, the company releases 26 A-line sweetheart evening dresses, and ... , “We are trying our best to help a ... designs. Along with affordable prices, we provide discounted delivery costs ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 BambooFlooringChina.com sells ... high quality bamboo flooring. Today, the company announces ... in many styles and colors. , BambooFlooringChina.com is the ... CEO, the promotion is valid until Jan. 20, 2015. ... strips and woven with a natural thread. All the ...
Breaking Medicine News(10 mins):Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 2Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
... Supplier of the Year by UHC and Novation for ... Consortium (UHC) and Novation, the healthcare industry,s leading contracting ... Incorporated (NYSE: OMX ), a ... 2009 recipient of UHC Service Excellence Supplier Award most ...
... Joseph,s Hospital in Tampa Named One of the ... St. Joseph,s Hospital, a member of BayCare ... the leading hospitals in the United States, in a study ... May/June issue of AARP The Magazine. Consumers, Checkbook is ...
... UC San Diego School of Medicine and the Moores UCSD ... system cell thought to be part of the first line ... spread. They have found that when these cells, known as ... cancer is more likely to spread to the lungs. ...
... the medical literature by a panel of experts at ... held this month in Phoenix concluded that there is ... greatest number of transfusions currently being given to patients. ... between red blood cell transfusions and higher rates of ...
... Abstract #5637DENVER, April 22 Scientists from ... Detroit presented data today at the American ... 2009 that signifies exciting research advancements in ... of breast cancer.(Logo: http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO )Researchers ...
... and Wellness and Reducing Common and Costly Chronic Disease ... to Senate and House LeadershipWASHINGTON, April 22 More ... Disease (PFCD) - an organization representing some of the ... on leaders in Congress to encourage updates in the ...
Cached Medicine News:Health News:OfficeMax Named the 2009 Recipient of The UHC Service Excellence Supplier Award 2Health News:OfficeMax Named the 2009 Recipient of The UHC Service Excellence Supplier Award 3Health News:Baycare Health System Hospital Earns National Recognition 2Health News:Instead of fighting breast cancer, immune cell promotes its spread 2Health News:Blood transfusions and outcomes 2Health News:Blood transfusions and outcomes 3Health News:Blood transfusions and outcomes 4Health News:Karmanos Cancer Institute Researchers Provide New Hope for Breast Cancer Treatment 2Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 2Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 3Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 4Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 5Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 6Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 7
... Medical Office (EMO) truly built for the ... needs of your practice. The ChartLogic™ EMO ... system (EMR, EHR, and EPR), and then ... level of efficiency and performance. In addition ...
... Optical dispensing is a part of about ... we have created a point of sale system. ... alone program or it can be integrated to ... the national Frames database. Glasses prescriptions, if ...
... This program module functions stand alone. It ... the ophthalmicsuite product. The ASC module is ... in ophthalmic surgical specialty. Cataract, cosmetic, strabismus, ... The ASC forms are adapted to your ...
... ChartLogic is an Electronic Medical ... and customized for the needs of ... and storing your charts electronically, an ... flow including documentation of patient encounters, ...
Medicine Products: